Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × letermovir × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 85 daratumumab 51 Lenalidomide 50 Bortezomib 33 Cyclophosphamide 31 pomalidomide 30 Calcium Dobesilate 24 carfilzomib 22 fludarabine 20 Specimen Handling 18 talquetamab 17 Magnetic Resonance Spectroscopy 17 Biopsy 16 iberdomide 15 isatuximab 14 belantamab mafodotin 14 dexamethasone acetate 12 selinexor 11 dexamethasone 21-phosphate 11 auricularum 11 venetoclax 9 elotuzumab 9 Melphalan 9 X-Rays 8 ixazomib 6 tocilizumab 5 fludarabine phosphate 5 Phantoms, Imaging 5 Blood Specimen Collection 5 ruxolitinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06920251 2025-12-03

OPTIMUS-EL

Seoul National University Hospital

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡